Aurinia Pharmaceuticals (AUPH) Operating Margin (2019 - 2025)
Historic Operating Margin for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Q3 2025 value amounting to 40.49%.
- Aurinia Pharmaceuticals' Operating Margin rose 231500.0% to 40.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 26.34%, marking a year-over-year increase of 411700.0%. This contributed to the annual value of 1.99% for FY2024, which is 502500.0% up from last year.
- Latest data reveals that Aurinia Pharmaceuticals reported Operating Margin of 40.49% as of Q3 2025, which was up 231500.0% from 28.69% recorded in Q2 2025.
- In the past 5 years, Aurinia Pharmaceuticals' Operating Margin registered a high of 40.49% during Q3 2025, and its lowest value of 5529.87% during Q1 2021.
- In the last 5 years, Aurinia Pharmaceuticals' Operating Margin had a median value of 38.97% in 2023 and averaged 382.87%.
- Per our database at Business Quant, Aurinia Pharmaceuticals' Operating Margin soared by 1455704800bps in 2021 and then crashed by -128000bps in 2023.
- Aurinia Pharmaceuticals' Operating Margin (Quarter) stood at 139.74% in 2021, then rose by 29bps to 98.82% in 2022, then skyrocketed by 33bps to 65.8% in 2023, then surged by 96bps to 2.79% in 2024, then surged by 1552bps to 40.49% in 2025.
- Its Operating Margin stands at 40.49% for Q3 2025, versus 28.69% for Q2 2025 and 34.97% for Q1 2025.